227 related articles for article (PubMed ID: 33952546)
1. Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Best KP; Collins CT
BMJ Open; 2021 May; 11(5):e044740. PubMed ID: 33952546
[TBL] [Abstract][Full Text] [Related]
2. Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial.
Gould JF; Makrides M; Sullivan TR; Anderson PJ; Gibson RA; Best KP; McPhee AJ; Doyle LW; Opie G; Travadi J; Cheong J; Davis PG; Sharp M; Simmer K; Collins CT
BMJ Open; 2021 Feb; 11(2):e041597. PubMed ID: 33550243
[TBL] [Abstract][Full Text] [Related]
3. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
[TBL] [Abstract][Full Text] [Related]
4. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
[TBL] [Abstract][Full Text] [Related]
5. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
[TBL] [Abstract][Full Text] [Related]
6. Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS).
Guillot M; Robitaille CA; Turner L; Pronovost E; Caouette G; Matte-Gagné C; Olivier F; Bartholomew J; Massé É; Morin A; Mohamed I; Marc I
BMJ Open; 2022 May; 12(5):e057482. PubMed ID: 35508343
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years.
Gould JF; Makrides M; Gibson RA; Sullivan TR; McPhee AJ; Anderson PJ; Best KP; Sharp M; Cheong JLY; Opie GF; Travadi J; Bednarz JM; Davis PG; Simmer K; Doyle LW; Collins CT
N Engl J Med; 2022 Oct; 387(17):1579-1588. PubMed ID: 36300974
[TBL] [Abstract][Full Text] [Related]
8. High doses of enteral docosahexaenoic acid omega-3 supplementation for prevention of bronchopulmonary dysplasia in very preterm infants: a protocol for a systematic review and meta-analysis.
Marc I; Boutin A; Pronovost E; Guillot M; Bergeron F; Moore L; Makrides M
BMJ Open; 2022 Oct; 12(10):e064515. PubMed ID: 36253040
[TBL] [Abstract][Full Text] [Related]
9. Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial.
Gould JF; Treyvaud K; Yelland LN; Anderson PJ; Smithers LG; Gibson RA; McPhee AJ; Makrides M
BMJ Open; 2016 May; 6(5):e011465. PubMed ID: 27188814
[TBL] [Abstract][Full Text] [Related]
10. Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis.
Marc I; Lavoie PM; McPhee AJ; Collins CT; Simonyan D; Pronovost E; Guillot M; Gould JF; Mohamed I; Beltempo M; Boutin A; Fortier I; Sullivan TR; Moore L; Makrides M
BMJ Open; 2023 Jul; 13(7):e076223. PubMed ID: 37518076
[TBL] [Abstract][Full Text] [Related]
11. Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.
Collins CT; Gibson RA; Anderson PJ; McPhee AJ; Sullivan TR; Gould JF; Ryan P; Doyle LW; Davis PG; McMichael JE; French NP; Colditz PB; Simmer K; Morris SA; Makrides M
BMJ Open; 2015 Mar; 5(3):e007314. PubMed ID: 25787990
[TBL] [Abstract][Full Text] [Related]
12. Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial.
Zhou SJ; Best K; Gibson R; McPhee A; Yelland L; Quinlivan J; Makrides M
BMJ Open; 2017 Sep; 7(9):e018360. PubMed ID: 28947468
[TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trial.
Gunaratne AW; Makrides M; Collins CT; Gibson RA; McPhee AJ; Sullivan TR; Gould JF; Green TJ; Doyle LW; Davis PG; French NP; Colditz PB; Simmer K; Morris SA; Best KP
Am J Clin Nutr; 2019 Jun; 109(6):1600-1610. PubMed ID: 31070712
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm.
Sullivan TR; Gould JF; Bednarz JM; McPhee AJ; Gibson R; Anderson PJ; Best KP; Sharp M; Cheong JLY; Opie GF; Travadi J; Davis PG; Simmer K; Collins CT; Doyle LW; Makrides M
JAMA Netw Open; 2023 Jun; 6(6):e2317870. PubMed ID: 37294565
[TBL] [Abstract][Full Text] [Related]
16. Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial.
Best KP; Sullivan TR; Gunaratne AW; Gould JF; Gibson RA; Collins CT; Makrides M; Green TJ
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678206
[TBL] [Abstract][Full Text] [Related]
17. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
18. DHA supplementation in infants born preterm and the effect on attention at 18 months' corrected age: follow-up of a subset of the N3RO randomised controlled trial.
Hewawasam E; Collins CT; Muhlhausler BS; Yelland LN; Smithers LG; Colombo J; Makrides M; McPhee AJ; Gould JF
Br J Nutr; 2021 Feb; 125(4):420-431. PubMed ID: 32660658
[TBL] [Abstract][Full Text] [Related]
19. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
